Navigation Links
Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types
Date:5/27/2009

acromegaly, a disease caused by a GH-secreting pituitary adenoma. Sandostatin LAR is not indicated as a treatment for tumor control. The clinical trials that supported approval of Sandostatin LAR did not study effect on tumor size or rate of growth.

The most frequently reported drug-related adverse events were biliary disorders (62%), gastrointestinal disorders (14% to 38%), and injection-site pain (20% to 50%). Hypoglycemia (4%), hyperglycemia (27%), sinus bradycardia (19%), conduction abnormalities (9%), and arrhythmias (3%) have been reported. Additional adverse reactions identified in clinical studies include nausea, abdominal pain, gas, constipation, vomiting, pain on injection, high or low blood sugar levels and slow or irregular heart rate. Many patients developed gallstones, although few patients required treatment.

For full prescribing information, please visit www.us.sandostatin.com.

Afinitor important safety information

Afinitor is approved in the US as the first oral, daily therapy (5 mg and 10 mg tablets) to treat patients with advanced renal cell carcinoma after failure of treatment with sunitinib or sorafenib. Afinitor is contraindicated in patients with hypersensitivity to everolimus, to other rapamycin derivatives or to any of the excipients. Potentially serious adverse reactions include non-infectious pneumonitis and infections for which patients should be monitored carefully and treated as needed. In addition, non-infectious pneumonitis may require temporary dose reduction and/or interruption or discontinuation. Patients with systemic invasive fungal infections should not receive Afinitor. Oral ulceration is a common side effect with Afinitor. Renal function, blood glucose, lipids and hematological parameters should be evaluated prior to the start of therapy with Afinitor and periodically thereafter. Strong or moderate CYP3
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Video: UCB Launches Vimpat(R) in the U.S. for Add-On Treatment of Epilepsy in Adults
2. Video: Partnership Unites UCB with Consumer Product Innovator OXO(R)
3. Video: ev3 Inc. Announces First Patient Enrollments in DEFINITIVE LE Post-Market Study
4. Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib
5. Video: Provectus PV-10 Interim Phase 2 Safety and Efficacy Results are as Good as or Better than Phase 1 Results
6. Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports
7. Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery
8. Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia
9. Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Dont Get Their Families Vaccinated
10. Video: Novartis Vaccines and PTA Battle Flu: Public Health Vaccination Initiative Urges Families Lets Fight Flu Together!
11. Video: Answer to Curing a Failing Heart May Exist in Bodys Own Do-It-Yourself Repair Kit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 2013   BioCision , a leader in ... in many areas of medical and scientific research, ... the U.S. Patent Office that apply to two ... sample handling to ensure the consistency of test ... procedures. Patent number 8,388,912 covers ...
(Date:6/19/2013)... India , June 19, 2013 ... Bureau has recently added DrugPatentWatch to ... ( http://www.bharatbook.com/drugpatentwatch-tour.pdf )      ... provides comprehensive information on pharmaceutical, drug ... information supports the critical business functions ...
(Date:6/19/2013)... , June 19, 2013 Amerivet ... company servicing all branches of government from Federal ... have expanded their facilities to include complex metal ... and fabricated some very complex aluminum parts for ... to expand our capabilities to service government contracts," ...
Breaking Medicine Technology:BioCision Announces Two New U.S. Patents for Thermo-Conductive Products that Standardize Sample Handling in Laboratory Research 2Drug Patent Watch 2Drug Patent Watch 3Amerivet Solutions Expands to Manufacture Complex Metal Designs 2
... SAN DIEGO, June 2, 2011 Biocept, Inc. today ... a poster at the 2011 Annual Meeting of the ... Chicago, Illinois June 3-7. The poster presentation is based ... logy C ell E nrichment and ...
... Kaiser Permanente Hawaii has received the inaugural Pharmacy ... Permanente,s achievement of a 5-star rating on the PQA ... Centers for Medicare and Medicaid Services (CMS) Star Rating ... because it uses publicly available quality data from CMS," ...
Cached Medicine Technology:Biocept and Academic Collaborators to Present Poster at ASCO on Circulating Tumor Cells (CTCs) 2Biocept and Academic Collaborators to Present Poster at ASCO on Circulating Tumor Cells (CTCs) 3PQA Recognizes Kaiser Permanente Hawaii for Excellence in Medication Safety 2
(Date:6/20/2013)... Hills, CA (PRWEB) June 20, 2013 ... M. Amron, has been named by The Patient’s Guide ... an expert in liposuction, Dr. Amron will now be ... Guide. The Patient's Guide sees over one million visitors ... information and articles related to plastic surgery and dermatology, ...
(Date:6/20/2013)... Dallas, Texas (PRWEB) June 20, 2013 ... of The Rhinoplasty Society, society president and keynote ... the past, present and future of rhinoplasty (plastic ... visiting the city from across the nation. ... from past closed-technique non-individualized rhinoplasty to current open-technique ...
(Date:6/20/2013)... Naples, FL (PRWEB) June 20, 2013 ... for a new-to-market supplement, Amaçari , made from ... energy boost is derived from the very high levels ... harvested Camu Camu berries from the Amazonian river basin ... a natural alternative for general health and wellbeing. , ...
(Date:6/20/2013)... InventHelp, America’s largest invention submission company, ... from Indiana, has designed hospital attire that could provide ... patented. , “Norma Jean’s” would feature ... strips along the sleeves. This design would allow hospital ... scans without the need to remove the patients clothing. ...
(Date:6/20/2013)... According to a new market research report ... DC Servo Motors/Drives, Brushless Servo Motors), Voltage Range (Low Voltage, ... - (2013 – 2018)" published by MarketsandMarkets, the total market ... by 2018, growing at an estimated CAGR of 6% from ... 102 Market Data Tables , 27 Figures ...
Breaking Medicine News(10 mins):Health News:Liposuction Guru, Dr. David Amron, Receives Award From The Patient’s Guide 2Health News:Dr. Rod J. Rohrich Delivers Keynote Address on the Future of Rhinoplasty 2Health News:Dr. Rod J. Rohrich Delivers Keynote Address on the Future of Rhinoplasty 3Health News:Dr. Rod J. Rohrich Delivers Keynote Address on the Future of Rhinoplasty 4Health News:Amaçari’s Alternative Health & Wellbeing Benefits 2Health News:InventHelp® Client Patents “Norma Jean’s” – Invention Could Keep Patients Warm and Comfortable 2Health News:Servo Motors & Drives Market to Reach 17.2 Million Units by 2018 - New Report by MarketsandMarkets 2Health News:Servo Motors & Drives Market to Reach 17.2 Million Units by 2018 - New Report by MarketsandMarkets 3
... the market-leading provider,of software for the control, management ... manage its interactions with the,media through the use ... the world,s leading pharmaceutical companies, is a,truly international ... with its,corporate office in London and major Research ...
... RIDGEWOOD, N.J., March 19 Goosie, LLC announced ... of Autism Awareness,Month throughout the month of April ... supporting families of autistic children with special,discounts. Goosie ... called,Goosie Cards(R). Goosie Cards are created online at ...
... Chronic fatigue syndrome (CFS) and fibromyalgia (FM) are ... cause and limited treatment options. However, results of ... treatment process that could help alleviate symptoms for ... M.D., medical director of the Holtorf Medical Group ...
... 19 Provena Mercy,Medical Center, a 356-bed ... levels of efficiency and physician satisfaction using ... solution from MedQuist (Pink Sheets: MEDQ). Radiologists ... percent of their,reports, and report turnaround time ...
... fast and precise ... ALTO, Calif., March 19 Varian Medical,Systems (NYSE: ... centers in North,America and Europe to further the development ... fast and precise,cancer treatments. RapidArc makes it possible to ...
... Dominate Market Despite Patent Expiries and, Increased Use of Fixed-Dose ... ... Decision Resources, WALTHAM, Mass., March 19 Decision Resources, one ... finds that sales of dyslipidemia therapies will decline,from $28 billion in ...
Cached Medicine News:Health News:Solcara Helps AstraZeneca Set International Benchmark for Global Media Relations 2Health News:Solcara Helps AstraZeneca Set International Benchmark for Global Media Relations 3Health News:Goosie Cards to Support Autism Awareness Month With Special Discount Program 2Health News:Data study suggests cortisol could alleviate for chronic fatigue syndrome and fibromyalgia 2Health News:Illinois Radiologists Self-Edit Reports, Reduce Turnaround Time with SpeechQ for Radiology(TM) 2Health News:Illinois Radiologists Self-Edit Reports, Reduce Turnaround Time with SpeechQ for Radiology(TM) 3Health News:Varian Announces Global Clinical Council to Develop RapidArc(TM) Cancer Treatments 2Health News:Varian Announces Global Clinical Council to Develop RapidArc(TM) Cancer Treatments 3Health News:Varian Announces Global Clinical Council to Develop RapidArc(TM) Cancer Treatments 4Health News:Varian Announces Global Clinical Council to Develop RapidArc(TM) Cancer Treatments 5Health News:Significant Generic Erosion Will Cause Sales of Dyslipidemia Drugs to Decline by $3.6 Billion by 2016 2
(1/4-15 LPM). 50 psi back inlet, wall mounted, 1/8" NPT female....
Value-Line oxygen flowmeters. ,Options: , For security chain, add suffix S to model number. Example: FMQ107S. , For Canadian Color-Code, add suffix FMQ104C. , For Double Flowmeters with Power Take-Of...
... Slim Line Flowmeters with brass ... For security chain, add suffix S ... For Canadian Color-Code, add suffix C ... For Double Flowmeters with Power Take-Off, ...
... Oxygen Adult Flowmeters, ,Options: ... suffix S to model number. ... Color-Code, add suffix C to ... For Double Flowmeters with Power ...
Medicine Products: